logo

For the Inventor, By the Inventor

Plymouth Meeting, PA, United States of America

Genaera Corporation


USPTO Granted Patents = 21

% Expired Patents = 66.7



Forward Citations = 157

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Nicholas C Nicolaides (16 out of 88 patents)

silverMedal Roy Clifford Levitt (16 out of 23 patents)

bronzeMedal Kenneth J Holroyd (8 out of 8 patents)

4.  W Lee Maloy (7 out of 18 patents)

5.  Yuhong Zhou (6 out of 16 patents)

6.  Mike McLane (6 out of 6 patents)

7.  Luigi Grasso (5 out of 72 patents)

8.  William Alvin Kinney (5 out of 65 patents)

9.  U Prasad Kari (4 out of 4 patents)

10.  Steve Jones (4 out of 4 patents)

11.  Michael A Zasloff (4 out of 56 patents)

12.  Jamila Louahed (3 out of 4 patents)

13.  Qu Dong (3 out of 3 patents)

14.  Jon I Williams (2 out of 15 patents)

15.  Michael McLane (1 out of 12 patents)


21 patents:

1. 7704710 - Interleukin-9 receptor mutants (2010-04-27),
2. 7700088 - Interleukin-9 mutein peptides (2010-04-20),
3. 7504409 - Mucin synthesis inhibitors (2009-03-17),
4. 7410959 - Therapeutic uses for aminosterol compounds (2008-08-12),
5. 7384767 - Nucleic acid encoding an interleukin-9 receptor variant (2008-06-10),
6. 7345051 - Mucin synthesis inhibitors (2008-03-18),
7. 7211254 - Methods for treating ICACC protein associated diseases (2007-05-01),
8. 7208292 - Nucleic acid encoding an interleukin-9 receptor variant (2007-04-24),
9. 7192578 - Interleukin-9 mutein peptides (2007-03-20),
10. 7074778 - Asthma associated factors as targets for treating atopic allergies including asthma and related disorders (2006-07-11),
11. 7056698 - Nucleic acids encoding interleukin-9 receptor variants (2006-06-06),
12. 6962909 - Treatment of neovascularization disorders with squalimine (2005-11-08),
13. 6933383 - Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols (2005-08-23),
14. 6737427 - Mucin synthesis inhibitors (2004-05-18),
15. 6716603 - Nucleic acids encoding a chloride channel protein (2004-04-06),
Genaera Corporation is a biopharmaceutical company focused on discovering and developing innovative therapies for metabolic diseases and cancer. With a strong emphasis on scientific research and clinical development, Genaera aims to address unmet medical needs and improve patient outcomes. Visit their website for more information.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

21 Patents

#5 in Plymouth Meeting, PA

#570 in Pennsylvania

#15,662 in US

#29,874 in the World

Plymouth Meeting, PA (US)
Plymouth Meeting, PA, United States of America

Genaera Corporation

Forward Citations = 157

24 inventors:

goldMedal Nicholas C Nicolaides (16 out of 88 patents)

silverMedal Roy Clifford Levitt (16 out of 23 patents)

bronzeMedal Kenneth J Holroyd (8 out of 8 patents)

4.  W Lee Maloy (7 out of 18 patents)

5.  Yuhong Zhou (6 out of 16 patents)

Please report any incorrect information to [email protected]
Loading…